ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500420 announcements Torrent Phar announcements and dividends declared BSE

Torrent Phar Complete list of announcements declared & dividend announcements by Torrent Phar 500420

Torrent Phar 500420 listed on BSE and deals in

Announcements and dividends declared by Torrent Phar 500420

Torrent Pharma to proceed with Rs 14,000 crore bond issue after regulatory nod, bankers say
In a significant move, Torrent Pharmaceuticals is set to issue bonds totaling up to 140 billion rupees after receiving the green light for its acquisition of JB Chemicals & Pharmaceuticals. This bond offering is poised to be the biggest rated issuance
Announcement as on 23 October 2025

Torrent Pharma plans Rs 14,000 crore bond sale for JB Chemicals acquisition
Torrent Pharmaceuticals is planning a ₹14,000-crore bond sale to finance its acquisition of JB Chemicals & Pharmaceuticals. The company is in discussions with major banks for the funding package, which will be repaid through internal accruals. The pr
Announcement as on 16 October 2025

Torrent Pharma gets demand notices totalling Rs 6.63 cr from NPPA
Torrent Pharmaceuticals reported receiving demand notices from the NPPA. The notices total over Rs 6.63 crore. They allege overcharging for five drugs between January 2016 and November 2018. The company stated these notices were received on October 3, 2025
Announcement as on 04 October 2025

Breakout Stocks: How to trade Torrent Pharma, EID Parry & Syrma SGS Technology that hit fresh 52-week high?
Indian markets rebounded smartly on Tuesday with Sensex rising over 400 points and Nifty closing above 24,800. Gains were led by healthcare, energy, and realty stocks. Torrent Pharma and EID Parry were among breakout performers hitting fresh 52-week highs.
Announcement as on 29 July 2025

Torrent Pharmaceuticals plans Semaglutide rollout post patent expiry
Torrent Pharmaceuticals is gearing up to launch both oral and injectable versions of semaglutide, the weight loss drug, following the expiration of Novo Nordisk's patent. The company is currently in Phase 3 clinical trials for oral products and has partner
Announcement as on 29 July 2025

Announcements by Torrent Phar first page | Next page | Prev page |

500420 Torrent Phar current price & indicator signals

Moving Averages for Torrent Phar

  • 5Day Average: 4401.95
  • 12Day Average: 4338.01
  • 20Day Average: 4265.1
  • 50Day Average: 4251.77
  • 100Day Average: 4129.99
  • 150Day Average: 3978.2
  • 200Day Average: 3885.25

500420 Indicators & signals

Indicator MACD (12,26,9)

4339.31, 4280.2, 42.49
Indicator MACD is in positive zone

Indicator ADX (14)

24.2, 27.5, 16.79
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500420 Torrent Phar are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Fri May 2026 4406.15 4385.25 to 4469.05 -0.07% 0.48 times
14 Thu May 2026 4409.10 4330.95 to 4422.70 2.65% 2.51 times
13 Wed May 2026 4295.20 4231.75 to 4405.80 -1.94% 0.7 times
12 Tue May 2026 4380.05 4370.45 to 4525.00 -3.08% 0.61 times
11 Mon May 2026 4519.25 4350.00 to 4555.95 3.17% 0.88 times
08 Fri May 2026 4380.35 4339.60 to 4399.00 0.49% 0.15 times
07 Thu May 2026 4358.95 4350.00 to 4402.00 0.03% 0.2 times
06 Wed May 2026 4357.50 4273.85 to 4437.00 1.91% 0.95 times
05 Tue May 2026 4275.95 4235.10 to 4293.90 0.56% 0.84 times
04 Mon May 2026 4252.05 4213.40 to 4279.10 1.44% 2.25 times
30 Thu Apr 2026 4191.50 4147.45 to 4256.85 -0.91% 0.92 times
29 Wed Apr 2026 4230.10 4200.40 to 4283.45 1.12% 0.31 times

Videos related to: 500420 announcements Torrent Phar announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500420 announcements Torrent Phar announcements and dividends declared BSE

 

Back to top